University of Texas M.D. Anderson Cancer Centers Proton Therapy Center.


January 13, 2010 – There is growing awareness about the advantages of proton therapy compared to conventional photon radiation therapy, especially when treating pediatric patients. Protons release most of their energy when they hit the tumor and deliver no exit dose beyond the tumor boundary, unlike photons. This enables the dose to better conform to the tumor and minimizes damage to healthy surrounding tissue, and enabling the radiation oncologist can potentially deliver an even greater dose. This less damaging deliver of dos is especially important when treating children by reducing radiation to growing and developing tissues.

As the proton therapy becomes more prevalent, the first proton-certified radiation therapists (RTTs) in the U.S. received advanced proton therapy certificates was notable. The RTTs earned their certificates at the Ivy Tech Community College-Bloomington program, which provides 16 college credits or the equivalent of two years of continuing education (CE) credits from the American Registry of Radiologic Technologists (ARRT). A portion of the program was held at the ProCure Training and Development Center in Bloomington, a training facility dedicated to proton therapy.

More specialized training in the field will be needed as more proton therapy spring up. Procure, a proton therapy center development company, is currently building a network of proton therapy treatment facilities across the United States. Construction is under way on a ProCure facility in suburban Chicago. Additional centers are in development in suburban Detroit, Mich., South Florida, Seattle, Wash., and Somerset, N.J.

For more information: www.ivytech.edu/bloomington and www.procure.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now